ストックスクリーナーアプリを入手
140.94
0.16%
0.22
前日終値:
$140.72
開ける：
$140.6
24時間の取引高:
1.17M
Relative Volume:
0.74
時価総額：
$9.09B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.40%
1か月 パフォーマンス:
+1.57%
6か月 パフォーマンス:
+5.03%
1年 パフォーマンス:
-4.83%
1日の値動き範囲:
$140.40
$141.57
1週間の範囲:
$139.56
$143.85
52週間の値動き範囲:
$107.43
$150.56
Ishares Biotechnology Etf Stock (IBB) Company Profile
IBB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
140.94 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.45 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
660.00 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
661.30 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.34 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
591.18 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf (IBB) 最新ニュース
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005 - MSN
BBH vs. IBB: How to Position for the Next Biotech Growth Cycle - AInvest
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
💸 Is there any unusual option activity or capital flow in tech ETFs? - AInvest
Vertex Pharmaceuticals Plunges 2.69%—Is This the Bottom for Vertex Pharmaceuticals? - AInvest
Health Care Stocks Slipped As Big Players Disappointed - Finimize
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday - 富途牛牛
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
State-Level Innovation Resilience in a Federal Funding Vacuum - AInvest
The Longevity Dividend: Unlocking AgeTech's Potential in a World of Extended Healthspans - AInvest
The Longevity Dividend: Unlocking Investment Opportunities in an Aging World - AInvest
Health Care Stocks Take A Tumble Across The Board - Finimize
RSG Q3 EPS Forecast Lowered by National Bank Financial - Defense World
William Blair Issues Positive Outlook for SOFI Earnings - Defense World
Sen. Markwayne Mullin Purchases Shares of Zoetis Inc. (NYSE:ZTS) - Defense World
Aurora Innovation (NASDAQ:AUR) Shares Gap Up on Strong Earnings - Defense World
Rep. Robert Bresnahan, Jr. Buys JPMorgan Chase & Co. (NYSE:JPM) Stock - Defense World
Atb Cap Markets Has Negative Estimate for NOV Q3 Earnings - Defense World
LPL Financial (NASDAQ:LPLA) Shares Acquired Sen. Markwayne Mullin - Defense World
Royal Bank Of Canada Lowers NOV (NYSE:NOV) Price Target to $18.00 - Defense World
B. Riley Reaffirms “Buy” Rating for Booking (NASDAQ:BKNG) - Defense World
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Raised to Neutral at JPMorgan Chase & Co. - Defense World
Susquehanna Boosts Boeing (NYSE:BA) Price Target to $270.00 - Defense World
Ishares Biotechnology Etf (IBB) 財務データ
Ishares Biotechnology Etf (IBB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.11%
大文字化:
|
ボリューム (24 時間):